What You Should Know:
– OMNY Health, the leading healthcare ecosystem known for facilitating compliant cross-industry data sharing launched its platform designed to power AI driven health technology companies, further cementing the company’s commitment to democratizing healthcare data.
– QuantHealth and ArisGlobal are just two of OMNY’s newest partners to leverage this new platform to power their organizational AI-driven needs. OMNY Health’s data network uniquely addresses Generative AI’s need for large de-identified structured and unstructured electronic health record (EHR) data sets across diverse provider and patient populations, further underscoring the platform as delivering the data infrastructure and rails for provider organizations to collaborate and fuel the development and use of effective AI solutions for advancing healthcare.
Advancing Healthcare through AI: OMNY Health’s Strategic Partnerships
OMNY Health™ is revolutionizing the healthcare landscape with its national data ecosystem, designed to fuel partnerships that enhance clinical outcomes and elevate patient care. The platform, which spans all fifty states and covers over 75 million patient lives, connects healthcare systems, specialty health networks, academic medical centers, and integrated delivery networks. By facilitating data sharing and research collaboration, OMNY Health is powering innovation where patients need it most.
A prime example of OMNY Health’s impact is its collaboration with QuantHealth and ArisGlobal, two AI-driven partners making significant strides in advancing healthcare. QuantHealth, the leading AI-driven clinical trial design company, utilizes a vast dataset of 350 million patients to improve clinical trial timelines, mitigate risks, and identify populations likely to respond to treatments. Through OMNY Health’s collaboration, QuantHealth’s pharmaceutical partners can expedite drug development using simulated clinical trials. This approach provides real-world evidence by predicting clinical trial outcomes, drug efficacy, and patient responses.
ArisGlobal, another key partner, is at the forefront of pharmacovigilance, safety monitoring, and reporting systems. With its LifeSphere® technology, ArisGlobal aims to transform safety signal validation and enable comprehensive, proactive signal detection. OMNY Health’s partnership with ArisGlobal demonstrates a commitment to improving healthcare through AI-enabled safety monitoring and reporting systems.
These collaborations exemplify OMNY Health’s dedication to accelerating diverse participation in clinical trials and supporting research programs that aim to save lives and improve patient outcomes. The company’s data ecosystem, reflecting more than seven years of historical data and encompassing over 2 billion clinical notes from 300,000+ providers across 200+ specialties, serves as a centralized resource for life sciences and healthcare provider groups. This comprehensive data layer empowers health tech companies to drive the next generation of innovation, ensuring that patients receive the best possible care.
“Our mission is to free data from silos, allowing it to be shared, analyzed, and morphed into life saving treatments and better care for patients,” said Mitesh Rao, CEO, OMNY Health. “Life science organizations and providers often struggle with time and budget constraints that hinder their ability to learn from their data. Our work powering AI-driven platforms can unblock this process by partnering with AI developers with data and tools to accelerate breakthrough therapies and monitor new therapies for safety signals to ensure patient populations remain safe.”
